Case Overview
Unexplained intrahepatic cholestasis presents a significant diagnostic challenge, often eluding conventional examinations. A retrospective study of 62 such patients demonstrates that Whole Exome Sequencing (WES) combined with advanced bioinformatics tools, particularly the RDDC Pathogenicity Predictor, can significantly enhance diagnostic efficiency. This strategy successfully identified a genetic cause in 33.87% (21/62) of patients, including several rare diseases, highlighting the crucial value of RDDC tools in assessing variant pathogenicity and aiding precise diagnosis.
Clinical Challenge
The etiology of intrahepatic cholestasis is diverse. After ruling out common causes like biliary obstruction and viral hepatitis, a substantial portion of patients remain undiagnosed. Traditional diagnostic methods often fail to cover the broad spectrum of potential genetic factors. This study focused on 62 rigorously selected patients with unexplained intrahepatic cholestasis, aiming to comprehensively screen for potential pathogenic gene variants using WES technology. However, WES generates vast amounts of genetic variation data, and accurately distinguishing pathogenic variants from benign ones becomes a critical bottleneck in the analysis.
RDDC Solution
To address this challenge, the research team integrated the RDDC Pathogenicity Predictor into their bioinformatics pipeline. This model is specifically designed to evaluate the potential harmfulness of genetic variants. After identifying candidate variants through WES, researchers used the RDDC model, along with other tools, to comprehensively score and predict their pathogenicity. This step was vital, helping researchers filter out the most likely disease-causing culprits from numerous variants.
Clinical Results
Through the combined application of WES and the RDDC Pathogenicity Predictor, the study successfully pinpointed genetic causes in 21 patients. Familial intrahepatic cholestasis syndromes (PFIC, BRIC, etc.) were the most common diagnoses.
ALG8 Gene-Related Case
Notably, in a middle-aged female patient with Polycystic Liver Disease (PLD), WES identified a variant in the ALG8 gene. After being assessed as a "pathogenic mutation" by the RDDC Pathogenicity Predictor, combined with her liver cyst phenotype, a diagnosis of ALG8-related rare disease was confirmed.
17q12 Microdeletion Syndrome Case
Similarly, RDDC's auxiliary analysis provided molecular evidence for the diagnosis of another patient with 17q12 microdeletion syndrome.
Clinical Significance
This case clearly demonstrates that combining WES with the RDDC Pathogenicity Predictor is an effective diagnostic strategy for unexplained intrahepatic cholestasis. By providing reliable variant pathogenicity assessments, the RDDC tool assists clinicians and researchers in identifying genetic causes (like ALG8-related PLD) that might be missed by conventional methods. This significantly increases the diagnostic rate and provides a solid molecular basis for subsequent genetic counseling and prenatal diagnosis strategies.
Content Source and Disclaimer
This article is a compilation and interpretation of the scientific study cited below, intended to highlight the application of RDDC bioinformatics tools. All research data and conclusions belong to the original authors and publication.
Original Article:
Wang J, Zheng Y, Xiong Q, Yang Y. Etiological spectrum, clinical features, and gene mutation analysis of 62 patients with unexplained intrahepatic cholestasis. Journal of Clinical Hepatology. 2025.
